Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia
about
Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in CambodiaHepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and SurvivalVirological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.The hepatitis C treatment revolution: how to avoid Asia missing outSlow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy.HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes.HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus.
P2860
Q35852326-7E0BA66D-A741-4C1C-8102-121A06ABBC80Q35942740-002AB4FA-3BE2-4DF6-B5BA-8AF80405CBE4Q36235577-2209D061-6F00-4E45-A519-0D074C1AD4EEQ36410265-2D62B2E3-3331-48DC-BDF8-D110574C8137Q37098184-A8269E3D-1A23-4FD7-9E08-F572BE12F088Q37375386-6C496703-9A6C-46D0-B35B-FBF4C9F8CA87Q38515906-C364D364-FE95-4098-8440-D608B283F63AQ38967636-F29E6CC9-628C-4AA3-8CC9-4DDD67510364Q39425755-E5358AF5-33D2-4C70-A6FE-7B9A835B1058Q40379966-1BD1D752-B11D-4728-AEE5-B29E70046A7CQ40627202-288A186C-EE01-48DB-8986-2BD643F2D0B2Q46251979-F1105EFE-A759-42F1-BBAA-AE4098D24336Q47593919-0036C467-37F4-41F5-B46A-FC3B2D4B8147Q55035204-173875A6-674A-4ABC-B5E8-DA6B43A96F56
P2860
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@ast
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@en
type
label
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@ast
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@en
prefLabel
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@ast
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@en
P2093
P2860
P1433
P1476
Hepatitis B and C co-infection ...... etroviral toxicity in Cambodia
@en
P2093
Kimcheng Choun
Lay Phirum
Lutgarde Lynen
Sopheak Thai
P2860
P304
P356
10.1371/JOURNAL.PONE.0088552
P407
P577
2014-02-12T00:00:00Z